Explore more publications!
Mississippi Healthcare Reporter
Submit Press Release

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 13, 2025

LiveWorld Reports Third Quarter 2025 Financial Results
November 13, 2025

LiveWorld Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
November 13, 2025

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Four SPR® Abstracts Honored with Awards at 24th Annual ASRA Pain Meeting
November 13, 2025

Four SPR® Abstracts Honored with Awards at 24th Annual ASRA Pain Meeting

Indeterminate GlobeNewswire
Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission
November 13, 2025

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Indeterminate GlobeNewswire
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
November 13, 2025

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Indeterminate GlobeNewswire
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2025
November 13, 2025

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2025

Indeterminate GlobeNewswire
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
November 13, 2025

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Indeterminate GlobeNewswire
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
November 13, 2025

Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented

Indeterminate GlobeNewswire
Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
November 13, 2025

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

Indeterminate GlobeNewswire
AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
November 13, 2025

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

Indeterminate GlobeNewswire
AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
November 13, 2025

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

Indeterminate GlobeNewswire
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
November 13, 2025

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

Indeterminate GlobeNewswire
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
November 13, 2025

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 13, 2025

Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire
Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting
November 13, 2025

Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting

Indeterminate GlobeNewswire
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
November 13, 2025

Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire
Pediatrician Dr. Lauren Crosby Shares How Nutrition Can Help Kids Learn and Thrive in the Classroom on YourUpdateTV
November 13, 2025

Pediatrician Dr. Lauren Crosby Shares How Nutrition Can Help Kids Learn and Thrive in the Classroom on YourUpdateTV

Indeterminate GlobeNewswire
MHRA genehmigt klinische Studie von BetaGlue Therapeutics für YntraDose™ bei nicht resezierbarem lokal fortgeschrittenem Pankreaskarzinom (uLA-PDAC)
November 13, 2025

MHRA genehmigt klinische Studie von BetaGlue Therapeutics für YntraDose™ bei nicht resezierbarem lokal fortgeschrittenem Pankreaskarzinom (uLA-PDAC)

Indeterminate GlobeNewswire
La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)
November 13, 2025

La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)

Indeterminate GlobeNewswire
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
November 13, 2025

SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions